For the quarter ending 2025-09-30, LRMR has $187,350K in assets. $48,312K in debts. $90,140K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 90,140 | 20,587 | ||
| Short-term marketable securities | 85,295 | 117,937 | ||
| Prepaid expenses and other current assets | 7,788 | 7,032 | ||
| Total current assets | 183,223 | 145,556 | ||
| Fixed assets, gross | 2,515 | - | ||
| Less accumulated depreciation | 1,806 | - | ||
| Property and equipment, net | 709 | 797 | ||
| Operating lease right-of-use assets | 2,270 | 2,468 | ||
| Restricted cash | 606 | 606 | ||
| Other assets | 542 | 561 | ||
| Total assets | 187,350 | 149,988 | ||
| Accounts payable | 11,100 | 4,169 | ||
| Accrued expenses | 32,865 | 21,351 | ||
| Operating lease liabilities, current | 1,151 | 1,129 | ||
| Total current liabilities | 45,116 | 26,649 | ||
| Operating lease liabilities | 3,196 | 3,485 | ||
| Total liabilities | 48,312 | 30,134 | ||
| Common stock, 0.001 par value per share 115,000,000 shares authorized as of september 30, 2025 and december 31, 2024 85,590,392 and 63,815,065 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively | 86 | 64 | ||
| Additional paid-in capital | 511,219 | 444,420 | ||
| Accumulated deficit | -372,333 | -324,621 | ||
| Accumulated other comprehensive gain | 66 | -9 | ||
| Total stockholders equity | 139,038 | 119,854 | ||
| Total liabilities and stockholders equity | 187,350 | 149,988 | ||
Larimar Therapeutics, Inc. (LRMR)
Larimar Therapeutics, Inc. (LRMR)